SAGE-817

N/A

Report date: 2025/04/01 15:33:50
NME

Base Information

Drug NameSAGE-817
Drug Alias NameSAGE-817
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor negative allosteric modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsNeurodevelopmental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSage Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSage Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeurodevelopmental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A